跳转到主要内容


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

白皮书

Product Alert – Relugolix API

Product Alert – Relugolix API

Relugolix is a medication used for the treatment of advanced prostate cancer, endometriosis- associated pain, and uterine fibroids. It works by suppressing the production of hormones that stimulate the growth of tumors or cause pain and other symptoms associated with these conditions.

Specifically, Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which means it blocks the action of GnRH, a hormone that regulates the production of other hormones such as testosterone in men and oestrogen in women. By blocking the GnRH receptor, Relugolix reduces the levels of these hormones, which can slow or stop the growth of prostate cancer cells or shrink uterine fibroids and relieve symptoms of endometriosis.

Dr. Reddy's API Offering

  • Dr. Reddy’s synthetic process is design around of Innovator Process.
  • We plan to offer anhydrous crystalline form (innovator form) and novel and stable crystalline form (Lab samples for the same are available).
  • cGMP API manufacturing facilities, successfully inspected by international regulatory authorities (TGA, WHO GMP, KFDA, PMDA, Health Canada, ANVISA and USFDA)​.
  • Genotoxic impurity (GTI) strategy as per ICH M7 guidelines and strategy for nitrosamine impurities are under evaluation..

To know more about our API offerings, please read the Tech sheet on Relugolix API by filling the contact form below.

Explore other Whitepapers:

Know More

Download Now

请填写下面的联系表以查看白皮书

给我们发电子邮件: api@drreddys.com | +91 40 49002222

免责声明

本目錄中的任何信息(包括對任何產品或服務的任何引用)均不構成銷售要約,或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是,只要存在此類監管豁免,就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估,並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途,但可用於第 107A 節。